Flanax Tablet, Film Coated
Product Images NDC 27854-160

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Flanax (NDC 27854-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Belmora Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Flanax 44-417 (Flanax 44 417 1)

Flanax 44-417 (Flanax 44 417 1)
Flanax is a pain reliever and fever reducer containing naproxen sodium or roxen sodium as an active component. It can temporarily relieve minor aches and pains associated with toothache, muscular aches, backache, the common cold, headache, menstrual cramps, and minor pain of arthritis. It can also temporarily reduce fever. However, it contains an NSAID, which can cause severe stomach bleeding, hives, skin reddening, blisters, and other allergic reactions. Therefore, it is important to know the instructions to take this drug. It is not recommended to use more than directed or for longer than directed. If the pain lasts more than 10 days or there is a difficulty in swallowing, one must stop using Flanax and ask the doctor. If any severe side effects are observed, seek medical assistance right away. Pregnant and breastfeeding women must consult their health care professional before using Flanax. Do not use Flanax if allergic to aspirin or before and after heart surgery. Keep this drug out of the reach of children. In case of overdose, contact the Poison Control Center.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.